Literature DB >> 19139101

A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.

Gretchen A Baltus1, Michael P Kowalski, Antonin V Tutter, Shilpa Kadam.   

Abstract

Large networks of proteins govern embryonic stem (ES) cell pluripotency. Recent analysis of the critical pluripotency factors Oct4 and Nanog has identified their interaction with multiple transcriptional repression complexes, including members of the mSin3A-HDAC complex, suggesting that these factors could be involved in the regulation of Oct4/Nanog function. mSin3A is critical for embryonic development, but the mechanism by which the mSin3A-HDAC complex is able to regulate ES cell pluripotency is undefined. Herein we show that the mSin3A-HDAC complex positively regulates Nanog expression in ES cells through Sox2, a critical ES cell transcription factor and regulator of Nanog. We have identified the mSin3A-HDAC complex to be present at the Nanog promoter only under proliferating conditions concurrent with histone acetylation. We find that Sox2 associates with mSin3A-HDAC complex members both in vitro and in vivo, similar to the interactions found between Oct4/Nanog and the mSin3A-HDAC complex. Knockdown of mSin3A-HDAC complex members or HDAC inhibitor treatment reduces Nanog expression, and overexpression of mSin3A-HDAC complex subunits stimulates Nanog expression. Our data demonstrate that the mSin3A-HDAC complex can positively regulate Nanog expression under proliferating conditions and that this activity is complementary to mSin3A-mediated p53-dependent silencing of Nanog during differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139101      PMCID: PMC2652339          DOI: 10.1074/jbc.M807670200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Histone deacetylases: silencers for hire.

Authors:  H H Ng; A Bird
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.

Authors:  Joseph B Rayman; Yasuhiko Takahashi; Vahan B Indjeian; Jan-Hermen Dannenberg; Steven Catchpole; Roger J Watson; Hein te Riele; Brian David Dynlacht
Journal:  Genes Dev       Date:  2002-04-15       Impact factor: 11.361

Review 3.  Cooperation between complexes that regulate chromatin structure and transcription.

Authors:  Geeta J Narlikar; Hua-Ying Fan; Robert E Kingston
Journal:  Cell       Date:  2002-02-22       Impact factor: 41.582

4.  Histone deacetylase activity is required for embryonic stem cell differentiation.

Authors:  Jeong-Heon Lee; Suzanne R L Hart; David G Skalnik
Journal:  Genesis       Date:  2004-01       Impact factor: 2.487

5.  The MAPK Hog1 recruits Rpd3 histone deacetylase to activate osmoresponsive genes.

Authors:  Eulàlia De Nadal; Meritxell Zapater; Paula M Alepuz; Lauro Sumoy; Glòria Mas; Francesc Posas
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

6.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression.

Authors:  Gerda Lagger; Dónal O'Carroll; Martina Rembold; Harald Khier; Julia Tischler; Georg Weitzer; Bernd Schuettengruber; Christoph Hauser; Reinhard Brunmeir; Thomas Jenuwein; Christian Seiser
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

7.  Regulation of human SRY subcellular distribution by its acetylation/deacetylation.

Authors:  Laurie Thevenet; Catherine Méjean; Brigitte Moniot; Nathalie Bonneaud; Nathalie Galéotti; Gudrun Aldrian-Herrada; Francis Poulat; Philippe Berta; Monsef Benkirane; Brigitte Boizet-Bonhoure
Journal:  EMBO J       Date:  2004-08-05       Impact factor: 11.598

8.  The corepressor mSin3A regulates phosphorylation-induced activation, intranuclear location, and stability of AML1.

Authors:  Yoichi Imai; Mineo Kurokawa; Yuko Yamaguchi; Koji Izutsu; Eriko Nitta; Kinuko Mitani; Masanobu Satake; Tetsuo Noda; Yoshiaki Ito; Hisamaru Hirai
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

9.  Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells.

Authors:  Yohei Okada; Takuya Shimazaki; Gen Sobue; Hideyuki Okano
Journal:  Dev Biol       Date:  2004-11-01       Impact factor: 3.582

10.  Integration of external signaling pathways with the core transcriptional network in embryonic stem cells.

Authors:  Xi Chen; Han Xu; Ping Yuan; Fang Fang; Mikael Huss; Vinsensius B Vega; Eleanor Wong; Yuriy L Orlov; Weiwei Zhang; Jianming Jiang; Yuin-Han Loh; Hock Chuan Yeo; Zhen Xuan Yeo; Vipin Narang; Kunde Ramamoorthy Govindarajan; Bernard Leong; Atif Shahab; Yijun Ruan; Guillaume Bourque; Wing-Kin Sung; Neil D Clarke; Chia-Lin Wei; Huck-Hui Ng
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

View more
  31 in total

1.  Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery.

Authors:  Harini Chakravarthy; Briana D Ormsbee; Sunil K Mallanna; Angie Rizzino
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

2.  Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.

Authors:  Josefine S Witteveen; Marjolein H Willemsen; Thaís C D Dombroski; Nick H M van Bakel; Willy M Nillesen; Josephus A van Hulten; Eric J R Jansen; Dave Verkaik; Hermine E Veenstra-Knol; Conny M A van Ravenswaaij-Arts; Jolien S Klein Wassink-Ruiter; Marie Vincent; Albert David; Cedric Le Caignec; Jolanda Schieving; Christian Gilissen; Nicola Foulds; Patrick Rump; Tim Strom; Kirsten Cremer; Alexander M Zink; Hartmut Engels; Sonja A de Munnik; Jasper E Visser; Han G Brunner; Gerard J M Martens; Rolph Pfundt; Tjitske Kleefstra; Sharon M Kolk
Journal:  Nat Genet       Date:  2016-07-11       Impact factor: 38.330

3.  Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug.

Authors:  Mandy Juarez; Alejandro Schcolnik-Cabrera; Guadalupe Dominguez-Gomez; Alma Chavez-Blanco; Jose Diaz-Chavez; Alfonso Duenas-Gonzalez
Journal:  Cancer Chemother Pharmacol       Date:  2020-05-30       Impact factor: 3.333

4.  The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency.

Authors:  Arven Saunders; Xin Huang; Miguel Fidalgo; Michael H Reimer; Francesco Faiola; Junjun Ding; Carlos Sánchez-Priego; Diana Guallar; Carmen Sáenz; Dan Li; Jianlong Wang
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

Review 5.  Multilayered control of gene expression by stress-activated protein kinases.

Authors:  Eulàlia de Nadal; Francesc Posas
Journal:  EMBO J       Date:  2009-11-26       Impact factor: 11.598

Review 6.  Concise review: pursuing self-renewal and pluripotency with the stem cell factor Nanog.

Authors:  Arven Saunders; Francesco Faiola; Jianlong Wang
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

7.  Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis.

Authors:  Marinus R Heideman; Cesare Lancini; Natalie Proost; Eva Yanover; Heinz Jacobs; Jan-Hermen Dannenberg
Journal:  Haematologica       Date:  2014-04-24       Impact factor: 9.941

8.  Dual roles of histone H3 lysine 9 acetylation in human embryonic stem cell pluripotency and neural differentiation.

Authors:  Yunbo Qiao; Ran Wang; Xianfa Yang; Ke Tang; Naihe Jing
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

Review 9.  Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.

Authors:  Hongwei Yao; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

10.  Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.

Authors:  Stephanie J Ellison-Zelski; Elaine T Alarid
Journal:  Mol Cancer       Date:  2010-09-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.